Recent developments in the production of human therapeutic proteins in eukaryotic algae

Expert Opinion on Biological Therapy

Volumn 5, Issue 2, 2005, Pages 225-235

  Franklin, Scott E ^a   Mayfield, Stephen P ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Algae; Monoclonal antibody expression; Therapeutic protein production

Indexed keywords

ABCIXIMAB; ADALIMUMAB; ALEFACEPT; ALEMTUZUMAB; BASILIXIMAB; BEVACIZUMAB; CETUXIMAB; DACLIZUMAB; EFALIZUMAB; ETANERCEPT; GEMTUZUMAB OZOGAMICIN; IBRITUMOMAB TIUXETAN; INFLIXIMAB; MONOCLONAL ANTIBODY; NATALIZUMAB; OMALIZUMAB; PALIVIZUMAB; RECOMBINANT PROTEIN; TOSITUMOMAB I 131; TRASTUZUMAB;

ALGA; ALLERGIC ASTHMA; BREAST CANCER; CELL TRANSFORMATION; CHLAMYDOMONAS REINHARDTII; CHLOROPLAST; COLORECTAL CANCER; COST CONTROL; EUKARYOTE; FERMENTATION; FINANCIAL MANAGEMENT; GENOME; HERPES SIMPLEX VIRUS; NONHODGKIN LYMPHOMA; NONHUMAN; PLASTID; PROTEIN EXPRESSION; PROTEIN PRODUCTION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW;

ALGAE, GREEN; ALGAL PROTEINS; ANIMALS; ANTIBODIES, MONOCLONAL; CHLAMYDOMONAS REINHARDTII; EUKARYOTIC CELLS; HUMANS; TECHNOLOGY, PHARMACEUTICAL;

EID: 15244346491     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.5.2.225     Document Type: Review

References (50)

1. BARBAS CF III, LERNER RA: Combinatorial immunoglobulin libraries on the surface of phage (Phabs): rapid selection of antigen specific Fabs. Methods (1991) 2:119-124.
2. HOOGENBOOM HR, GRIFFITHS AD, JOHNSON KS, CHISWELL DJ, HUDSON P, WINTER G: Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains. Nucleic Acids Res. (1991) 19:4133-4137.
3. GREEN LL: Antibody engineering via genetic engineering of the mouse: XenoMouse strains are a vehicle for the facile generation of therapeutic human monoclonal antibodies. J. Immunol. Meth. (1999) 231:11-23.
4. SANZ L, BLANCO B, ALVAREZ-VALLINA L: Antibodies and gene therapy: teaching old 'magic bullets' new tricks. Trends Immunol. (2004) 25:85-91.
5. CENTERS FOR DISEASE CONTROL AND PREVENTION: National Vital Statistics Report (2003) 52:1-114.
6. BAKER SD, VERWEIJ J, ROWINSKY EK et al.: Role of body surface area in dosing of investigational anticancer agents in adults, 1991-2001. J. Natl. Cancer Inst. (2002) 94(24):1883-1888.
7. NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES: Fact Sheet #9. Asthma and its environmental triggers: Scientists take a practical new look at a familiar illness. July (1997).
8. UBS INVESTMENT RESEARCH: The Q Series™: The State of Biomanufacturing. (2003):1-52.
9. DOVE A: Uncorking the biomanufacturing bottleneck. Nat. Biotechnol. (2002) 20:777-779.
10. WARD M, LIN C, VICTORIA DC et al.: Characterization of humanized antibodies secreted by Apsergillus niger. Appl. Environ. Microbiol. (2004) 70:2567-2576.
11. HIATT A, CAFFERKY R, BOWDISH K: Production of antibodies in transgenic plants. Nature (1988) 342:76-78. First example of antibody expression and assembly in higher plants via nuclear gene expression. However, such antibodies are glycosylated in a plant-specific fashion.
12. MA JK, LEHNER T, STABILA P, FUX CI, HIATT A: Assembly of monoclonal antibodies with IgG1 and IgA heavy chain domains in transgenic tobacco plants. Eur. J. Immunol. (1994) 24:131-138.
13. MA JK, HIATTA, HEIN M et al.: Generation and assembly of secretory antibodies in plants. Science (1995) 268:716-719.
14. MA JK, HIKMAT BY, WYCOFF K et al.: Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans. Nat. Med. (1998) 4:601-606.
15. ELLSTRAND NC: When transgenes wander, should we worry? Plant Physiol. (2001) 125:1543-1545. Very thoughtful discussion on the implications of genetically modified organisms on food crops, as well as substantial supportive data.
16. QUIST D, CHAPELA I: Transgenic DNA introgressed into traditional maite landraces in Oaxaca, Mexico. Nature (2001) 414:541-543.
17. BECKIE H: Impact of herbicide resistant crops as weeds in Canada. Proceedings of the Brighton Crop Protection Conference - Weeds (2001):135-142.
18. HALL L, TOPINKA K, HUFFMAN J, DAVIS L, GOOD A: Pollen flow between herbicide-resistant Brassica napus is the cause of multiple resistant B. napus volunteers. Weed Sci. (2000) 48:493-503.
19. BUCCHINI L, GOLDMAN LR: Starlink corn: a risk analysis. Environ. Health Perspect. (2002) 110:5-13.
20. BERNSTEIN JA, BERNSTEIN IL, BUCCHINI L et al.: Clinical and laboratory investigation of allergy to genetically modified foods. Environ. Health Perspect. (2003) 111:1114-1121.
21. STAUB JM, GARCIA B, GRAVES J et al.: High-yield production of a human therapeutic protein in tobacco chloroplasts. Nat. Biotechnol. (2000) 18:333-338.
22. KOTA M, DANIELL H, VARMA S, GARCZYNSKI SF, GOULD F, MOAR WJ: Overexpression of the Bacillus thuringiensis (Bt) Cry2Aa2 protein in chloroplasts confers resistance to plants against susceptible and Bt-resistant insects Proc. Natl. Acad. Sci. USA (1999) 96:1840-1845.
23. SIDOROV VA, KASTEN D, PANG SZ, HAJDUKIEWICZ PT, STAUB JM, NEHRA NS: Stable chloroplast transformation in potato: use of green fluorescent prorein as a plastid marker. Plant J. (1999) 19:209-216.
24. RUF S, HERRMANN M, BERGER I, CARRER I, BOCK R: Stable genetic transformation of tomato plastids and expression of a foreign protein in fruit. Nat. Biotechnol. (2001) 19:870-875.
25. HEIFETZ PB: Genetic engineering of the chloroplast. Biochimie (2000) 82:655-666. Extensive overview of the landscape of recombinant proteins expressed to date in plastids, primarily chloroplasts, in higher plants.
26. FRANKLIN SE, NGO B, EFFUET E, MAYFIELD SP: Development of a GFP reporter gene for Chlamydomonas reinhardtii chloroplast. Plant J. (2002) 30:733-744. Demonstrated that codon optimisation had a profound effect on recombinant protein accumulation.
27. MAYFIELD SP, FRANKLIN SE, LERNER RA: Expression and assembly of a fully active antibody in algae. Proc. Natl. Acad. Sci. USA (2003) 100:438-442. The first demonstration that an antibody could be expressed in the chloroplast of any species, and that it assembled into a functional antigen-binding protein.
28. MAYFIELD SP, SCHULTZ J: Development of a luciferase reporter gene, luxCt, for Chlamydomonas reinhardtii chloroplast. Plant J. (2004) 37:449-458.
29. FRANKLIN SE, MAYFIELD SP: Prospects for molecular farming in the green alga Chlamydomonas reinhardtii. Curr. Opin. Plant Biol. (2004) 7:159-165.
30. HARRIS EH: The Chlamydomonas Sourcebook: A Comprehensive Guide to Biology and Laboratory Use. Harris EH (Ed.), Academic Press, Inc., New York, NY, USA (1989).
31. CERUTTI H, JOHNSON AM, GILHAM NW, BOYNTON NE: A eubacterial gene conferring spectinomycin resistance on Chlamydomonas reinhardtii: integration into the nuclear genome and gene expression. Genetics (1997) 145:97-110.
32. CERUTTI H, JOHNSON AM, GILHAM NW, BOYNTON NE: Epigenetic silencing of a foreign gene in nuclear transformants of Chlamydomonas. Plant Cell (1997) 9:925-945.
33. BOYNTON JE, GILLHAM NW, HARRIS EH et al.: Chloroplast transformation in Chlamydomonas with high velocity microprojectiles. Science (1988) 240:1534-1538.
34. NEWMAN SM, BOYNTON JE, GILLHAM NW, RANDOLPH-ANDERSON BL, JOHNSON AM, HARRIS EH: Transformation of chloroplast ribosomal RNA in Chlamydomonas: molecular and genetic characterization of integration events. Genetics (1990) 126:875-888.
35. ROCHAIX JD, MERCHANT S, GOLDSCHMIDT-CLERMONT M: The Molecular Biology of Chloroplasts and Mitochondria in Chlamydomonas. Rochaix JD, Merchant S, Goldschmidt-Clermont M (Eds), Kluwer Academic Publishers, New York, NY, USA (2000).
36. GOLDSCHMIDT-CLERMONT M: Transgenic expression of aminoglycoside adenine transferase in the chloroplast: a selectable marker for site-directed transformation of Chlamydomonas. Nucleic Acids Res. (1991) 19:4083-4089.
37. ELLIOTT S, LORENZINI T, ASHER S et al.: Enhancement of therapeutic protein in vivo activities through glycoengineering. Nat. Biotechnol. (2003) 21:414-421.
38. SIMMONS L, REILLY D, KLIMOWSKI L et al.: Expression of full-length immunoglobulins in Escherichia coli: rapid and efficient production of aglycosylated antibodies. J. Immunol. Meth. (2003) 263:133-147.
39. TAO MH, MORRISON SL: Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region. J. Immunol. (1989) 143:2595-2601.
40. DORAI H, MUELLER BM, REISFELD RA, GILLIES SD: Aglycosylated chimeric mouse/human IgG1 antibody retains some effector function. Hybridoma (1991) 10:211-217.
41. HAND P, CALVO B, MILENIC D et al.: Comparative biological properties of a recombinant chimeric anti-carcinoma mAb and a recombinant aglycosylated variant. Cancer Immunol. Immunother. (1992) 35:165-174.
42. WALTON W, NGUYEN VT, BUTNEV V, SINGH V, MOORE WT, BOUSFIELD GR: Characterization of human FSH isoforms reveals a nonglycosylated B-subunit in addition to the conventional glycosylated B-subunit. J. Clin. Endocrinol. (2001) 86:3675-3685.
43. BRUE T, CARUSO E, MORANGE I et al.: Immunoradiometric analysis of circulating human glycosylated and nonglycosylated prolactin forms: spontaneous and stimulated secretions. J. Clin. Endocrinol. Metab. (1992) 75:1338-1344.
44. PRICE AE, LOGVINENKO KB, HIGGINS EA, COLE ES, RICHARDS SM: Studies on the microheterogeneity and in vitro activity of glycosylated and nonglycosylated recombinant human prolactin separated using a novel purification process. Endocrinology (1995) 136:4827-4833.
45. MAKIMATTILA S, FINEMAN MS, YKI-JARVINEN H: Deficiency of total and nonglycosylated amylin in plasma characterizes subjects with impaired glucose tolerance and type 2 diabetes. J. Clin. Endocrinol. Metab. (2000) 85:2822-2827.
46. FRIEND PJ, HALE G, CHATENOUD L et al.: Phase I study of an engineered aglycosylated humanized CD3 antibody in renal transplant rejection. Transplantation (1999) 68:1632-1637.
47. CHATENOUD L: CD3-specific antibody-induced active tolerance: from bench to bedside. Nat. Rev. Immunol. (2003) 3:123-132.
48. ROCHAIX JD: Post-transcriptional regulation of chloroplast gene expression in Chlamydomonas. Plant Mol. Biol. (1996) 32:327-341.
49. EBERHARD S, DRAPIER D, WOLLMAN FA: Searching limiting steps in the expression of chloroplast encoded proteins: relations between gene copy number, transcription, transcript abundance and translation rate in the chloroplast of Chlamydomonas reinhardtii. Plant J. (2002) 31:149-160. Clear demonstration that translation is the key modulator of chloroplast gene expression in C. reinhardtii. A critical point for deciding how to impact therapeutic protein production in this organism.
50. EIBL C, ZOU Z, BECK A, KIM M, MULLET J, KOOP HU: In vivo analysis of plastid psbA, rbcL and rpl32 UTR elements by chloroplast transformation: tobacco plastid gene expression is controlled by modulation of transcript levels and translation efficiency. Plant J. (1999) 19:333-345.